Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Beleave Inc. BLEVF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
15/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Beleave Inc. (BLEVF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 14/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $2M, +0%/yr average growth. Net income is $34M (loss), growing at -133.6%/yr. Net profit margin is -1423% (negative). Gross margin is 34.4% (+0 pp trend).

Balance sheet: total debt is $11M against $10M equity (Debt-to-Equity (D/E) ratio 1.04, moderate). Current ratio is 0.41 (tight liquidity). Debt-to-assets is 46%. Total assets: $24M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 17/100 (Fail), Moat 32/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

BLEVF SharesGrow Score Overview

19/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 32/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BLEVF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
BLEVF: +0%/yr revenue is, -133.6%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
17/100
Balance sheet BLEVF: Debt-to-Equity (D/E) ratio 1.04 (moderate), Current ratio is 0.41 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
32/100
BLEVF: Gross margin is 34.4% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 32/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
BLEVF: Net profit margin is -1423%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.0001
Volume1.05K
Avg Volume (30D)1.9K
Market Cap$566.00
Beta (1Y)-148.45
Share Statistics
EPS (TTM)-0.08
Shares Outstanding$409.22M
IPO Date2016-09-28
CEOVasilios Panagiotakopoulos
Financial Highlights & Ratios
Revenue (TTM)$2.37M
Gross Profit$816.46K
EBITDA$-20.59M
Net Income$-33.78M
Operating Income$-23.49M
Total Cash$538.24K
Total Debt$10.85M
Net Debt$10.32M
Total Assets$23.61M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA0775611084

Price Chart

Track all markets on TradingView
BLEVF
Beleave Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

CBWTF
CBWTF
Auxly Cannabis Group Inc.
$0.10
+11.56%
 COPHF
COPHF
Creso Pharma Limited
$0.12
+0.00%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 CNPOF
CNPOF
RIV Capital Inc.
$0.08
+0.00%
 TRUFF
TRUFF
Red Light Holland Corp.
$0.02
+0.46%
 PCLOF
PCLOF
PharmaCielo Ltd.
$0.03
-7.67%
 BCBCF
BCBCF
The BC Bud Corporation
$0.04
-3.31%
 HYEX
HYEX
Healthy Extracts Inc.
$1.60
-1.84%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message